Page last updated: 2024-09-05

dabigatran and Idiopathic Parkinson Disease

dabigatran has been researched along with Idiopathic Parkinson Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Grammas, P; Iannucci, J; Johnson, SL; Seeram, NP1
Abd El Fattah, MA; Ahmed, LA; El-Sayeh, BM; Kandil, EA; Sayed, RH1

Other Studies

2 other study(ies) available for dabigatran and Idiopathic Parkinson Disease

ArticleYear
Inhibiting thrombin improves motor function and decreases oxidative stress in the LRRK2 transgenic Drosophila melanogaster model of Parkinson's disease.
    Biochemical and biophysical research communications, 2020, 06-25, Volume: 527, Issue:2

    Topics: Animals; Animals, Genetically Modified; Antithrombins; Dabigatran; Disease Models, Animal; Drosophila melanogaster; Female; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Locomotion; Male; Mutation; Oxidative Stress; Parkinson Disease; Thrombin

2020
Modulatory Role of Nurr1 Activation and Thrombin Inhibition in the Neuroprotective Effects of Dabigatran Etexilate in Rotenone-Induced Parkinson's Disease in Rats.
    Molecular neurobiology, 2018, Volume: 55, Issue:5

    Topics: alpha-Synuclein; Animals; Dabigatran; Dopamine; Dopaminergic Neurons; Inflammation; Male; Neostriatum; Neuroprotective Agents; Nuclear Receptor Subfamily 4, Group A, Member 2; Parkinson Disease; Rats, Wistar; Rotenone; Substantia Nigra; Thrombin

2018